Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 1/2018

01-01-2018 | Short Communication

Association between echocardiographic epicardial adipose tissue and E/e′ ratio in obese adults

Authors: Leire Moreno-Galdós, Joaquín Barba-Cosials, Jorge M. Núñez-Córdoba

Published in: Acta Diabetologica | Issue 1/2018

Login to get access

Excerpt

Epicardial fat has emerged as an organ-specific adiposity depot of interest for the stratification of cardiometabolic risk factors. Potential mechanisms underlying the association between epicardial adipose tissue (EAT) and cardiac changes show biological plausibility [1]. …
Literature
1.
Iacobellis G (2015) Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11:363–371CrossRefPubMed
2.
Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133CrossRefPubMed
3.
Fontes-Carvalho R, Sampaio F, Teixeira M, Rocha-Gonçalves F, Gama V, Azevedo A et al (2015) Left ventricular diastolic dysfunction and E/E′ ratio as the strongest echocardiographic predictors of reduced exercise capacity after acute myocardial infarction. Clin Cardiol 38:222–229CrossRefPubMed
4.
Iacobellis G, Singh N, Wharton S, Sharma AM (2008) Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring). 16:1693–1697CrossRefPubMed
5.
Aldiss P, Davies G, Woods R, Budge H, Sacks HS, Symonds ME (2017) ‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk. Int J Cardiol 228:265–274CrossRefPubMedPubMedCentral
Metadata
Title
Association between echocardiographic epicardial adipose tissue and E/e′ ratio in obese adults
Authors
Leire Moreno-Galdós
Joaquín Barba-Cosials
Jorge M. Núñez-Córdoba
Publication date
01-01-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1040-8

Other articles of this Issue 1/2018

Acta Diabetologica 1/2018 Go to the issue

Case Report

Non-clostridial gas gangrene in a patient with poorly controlled type 2 diabetes mellitus on hemodialysis

Review Article

Health literacy in type 2 diabetes patients: a systematic review of systematic reviews

Original Article

Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4

Original Article

Routine resting energy expenditure measurement increases effectiveness of dietary intervention in obesity

Original Article

Implication of decreased serum complement 3 in patients with diabetic nephropathy

Short Communication

Physical activity levels of patients with type 2 diabetes in hospital and at home
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits